Diagnóstico y tratamiento de las lesiones intraepiteliales escamosas de alto grado del cuello uterino
Resumen
INTRODUCCIÓN. El cáncer cérvico-uterino tiene una fase precursora de larga duración, pues debe pasar por varios estados previos al cáncer invasivo, denominados lesiones intraepiteliales, de bajo y de alto grado, que pueden transformarse en lesiones malignas. La importancia de un diagnóstico oportuno y certero de las lesiones intraepiteliales escamosas de alto grado radica en que, si son tratadas de manera oportuna, son ciento por ciento curables. OBJETIVO. Proporcionar información actualizada sobre el diagnóstico y tratamiento de las lesiones precursoras de cáncer de cérvix y ayudar a los profesionales en la toma de decisiones médicas. MATERIALES Y MÉTODOS. Estudio de revisión de 45 artículos científicos la gran mayoría de la última década y, unos pocos, con datos históricos vigentes sobre lesiones intraepiteliales escamosas de alto grado del cuello uterino. La búsqueda se realizó en MedLine, PLoS y Scielo utilizando los términos tamizaje, neoplasias uterinas, lesiones intraepiteliales escamosas de cuello uterino y tratamiento. RESULTADOS. Los artículos científicos fueron seleccionados por niveles de evidencia 1 y 2, con recomendaciones A y B. Las recomendaciones de inicio de tamizaje han cambiado y el manejo toma en cuenta el riesgo acumulado por tipo de lesión. El tratamiento, en la mayoría de casos, es la escisión y resulta definitivo. CONCLUSIÓN. El diagnóstico sigue siendo cito-colpo-histológico y el tratamiento depende de la edad de la paciente, pudiendo las posibilidades ir de la observación hasta la escisión quirúrgica y, en casos específicos, la histerectomía.
Descargas
Citas
Crum C, McLachlin C. Cervical intraepithelial neoplasia. J Cell Biochem Suppl [Internet]. 1995 [cited 2018 Sep 3]; 23:71-9. DOI: https://doi.org/10.1002/jcb.240590910. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/jcb.240590910
Zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology [Internet]. 2009 Feb 20 [cited 2018 Sep 3]; 384(2):260-5. DOI: 10.1016/j.virol.2008.11.046. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19135222
Rodríguez C, Padilla G. Cáncer de cérvix y autorresponsabilidad: perfilando el riesgo de abstención al Papanicolaou entre las mujeres chilenas mediante Árboles de Decisión. Horiz. Med Lima [Internet]. 2018 ene/mar [citado 2018 Sep 3]; vol.18, n.1, pp.13-22. ISSN 1727-558X. DOI: http://dx.doi.org/10.24265/horizmed.2018.v18n1.03. Disponible en: http://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/702
Massad L, Einstein M, Huh W, Katki H, Kinney W, Schiffman M, Solomon D, Wentzensen N, Lawson H. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol [Internet]. 2013 Apr [cited 2018 Sep 3]; 121(4):829-46. PMID: 23635684. DOI: 10.1097/AOG.0b013e3182883a34. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23635684
Zhao F, Lewkowitz A, Hu S, Chen F, Li L, Zhang Q, Wu R, Li C, Wei L, Xu A, Zhang W, Pan Q, Zhang X, Belinson J, Sellors J, Smith J, Qiao Y, Franceschi S. Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. Int J Cancer [Internet]. 2012 Dec [cited 2018 Sep 3]; 15;131(12):2929-38. DOI: 10.1002/ijc.27571. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22488743
Vivar N, Loayza F, Astudillo Y, Ruiz A, Cruz C. Prevalencia de infección por virus de papiloma humano de alto riesgo oncogénico en mujeres de 30 a 65 años afiliadas al Seguro Social. Revista Médica-Científica CAMbios [Internet]. 2014 Dic [citado 2018 Sep 3]; XXII (22):5-9. ISSN: 1390 – 5511. Disponible en: https://hcam.iess.gob.ec/wp-content/uploads/revista-cambios/REVISTA%2022%20imprenta.pdf
Broso P, Buffetti G. The Papanicolaou classification in the Bethesda system (National Cancer Institute, Bethesda, Maryland). Minerva Ginecol [Internet]. 1993 Nov [cited 2018 Sep 3]; 45(11):557-63. PMID: 8121604. Available from: https://www.ncbi.nlm.nih.gov/pubmed/8121604
Apgar B, Zoschnick L, Wright T Jr. The 2001 Bethesda System terminology. Am Fam Physician [Internet]. 2003 Nov [cited 2018 Sep 3]; 68(10):1992-8. Available from: https://www.aafp.org/afp/2003/1115/p1992.html
Darragh T, Colgan T, Thomas Cox J, Heller D, Henry M, Luff R, et al. The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Journal of Lower Genital Tract Disease [Internet]. 2013 Jan [cited 2018 Sep 3]; 32(1):76-115. DOI: 10.1097/PGP.0b013e31826916c7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23202792
Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, Young N. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA [Internet]. 2002 [cited 2018 Sep 4]; 287:2114. PMID: 11966386. DOI:10.1001/jama.287.16.2114. Available from: https://jamanetwork.com/journals/jama/article-abstract/194863
Insinga R, Glass A, Rush B. Diagnoses and outcomes in cervical cancer screening: a population-based study. Am J Obstet Gynecol [Internte]. 2004 Jul [cited 2018 Sep 4]; 191(1):105-13. PMID: 15295350. DOI: 10.1016/j.ajog.2004.01.043. Available from: https://www.ncbi.nlm.nih.gov/pubmed/15295350
Katki H, Schiffman M, Castle P, Fetterman B, Poitras N, Lorey T, Cheung L, Raine-Bennett T, Gage J, Kinney WK. Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines. J Low Genit Tract Dis [Internet]. 2013 Apr [cited 2018 Sep 4]; 17:S28. PMID: 23519302. PMCID: PMC3616419. DOI: 10.1097/LGT.0b013e318285423c. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23519302
Kahn J. HPV vaccination for the prevention of cervical intraepithelial neoplasia. N Engl J Med [Internet]. 2009 Jul [cited 2018 Sep 4]; 361 (3): 271-8. PMID: 19605832. DOI: 10.1056/NEJMct0806938. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19605832
Catarino R, Vassilakos P, Jinoro J, Broquet C, Benski A, Meyer-Hamme U, Petignat P. Human papillomavirus prevalence and type-specific distribution of high- and low-risk genotypes among Malagasy women living in urban and rural areas. Cancer Epidemiol [Internet]. 2016 Jun [cited 2018 Sep 4]; 42:159-66. PMID: 27161432. DOI: 10.1016/j.canep.2016.04.013. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27161432
Ho G, Bierman R, Beardsley L, Chang C, Burk R. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med [Internet]. 1998 Feb 12 [cited 2018 Sep 4]; 338(7):423-8. PMID: 9459645. DOI: 10.1056/NEJM199802123380703. Available from: https://www.ncbi.nlm.nih.gov/pubmed/9459645
Janerich D, Hadjimichael O, Schwartz P, Lowell D, Meigs J, Merino M, Flannery J, Polednak A. The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health [Internet]. 1995 Jul [cited 2018 Sep 4]; 85(6):791. DOI: 10.2105/AJPH.85.6.791. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1615485/
International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8097 women with squamous cell carcinoma and 1374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer [Internet]. 2007 Feb 15 [cited 2018 Sep 4]; 120(4):885-91. DOI:10.1002/ijc.22357. Available from: https://www.ncbi.nlm.nih.gov/pubmed/17131323
Quinn M, Babb P, Jones J, Allen E. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ [Internet]. 1999 Apr [cited 2018 sep 10]; 318(7188):904-8. DOI: 10.1136/bmj.318.7188.904. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC27810/
Taylor R, Morrell S, Mamoon H, Wain G, Ross J. Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia). Cancer Causes Control [Internet]. 2006 [cited 2018 sep 10]; 17 (3): 299. DOI: 10.1007/s10552-005-0515-z. Available from: https://www.ncbi.nlm.nih.gov/pubmed/16489537
Aklimunnessa K, Mori M, Khan MM, Sakauchi F, Kubo T, Fujino Y, et al. Effectiveness of cervical cancer screening over cervical cancer mortality among Japanese women. Jpn J Clin Oncol [Internet]. 2006 Sep [cited 2018 sep 10]; 36 (8): 511. DOI:10.1093/jjco/hyl060. Available from: www.researchgate.net/publication/6940563_Effectiveness_of_Cervical_Cancer_Screening_Over_Cervical_Cancer_Mortality_Among_Japanese_Women
Vaccarella S, Franceschi S, Engholm G, Lönnberg S, Khan S, Bray F. 50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence. Br J Cancer [Internet]. 2014 Aug [cited 2018 Sep 10]; 111 (5): 965-9. Epub 2014 Jul 03. DOI: 10.1038/bjc.2014.362. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24992581
OPS-OMS. Control Integral del cáncer cérvicouterino: guía de prácticas esenciales [Internet]. 2015 Dic [citado 2018 Sep 10]: segunda edición en español. ISBN: 978 92 75 318799. Disponible en: http://iris.paho.org/xmlui/bitstream/handle/123456789/28512/9789275318799_spa.pdf
National Cancer Institute Factsheet. Human papillomavirus and cancer: Questions and answers. Centers for Disease Control and Prevention [Internet]. 2019 May [Cited 2019 Jun 10]. Available from: www.cancer.gov/cancertopics/factsheet/Risk/HPV
Cox J. Human papillomavirus testing in primary cervical screening and abnormal Papanicolaou management. Obstet Gynecol Surv [Internet]. 2006 Jun [citado 2018 Sep 10]; 61(6 Suppl 1):S15-25. DOI: 10.1097/01.ogx.0000221011.01750.25. Available from: https://journals.lww.com/obgynsurvey/Abstract/2006/06001/Human_Papillomavirus_Testing_in_Primary_Cervical.4.aspx
Jin Y1, Pan L. Role of high-risk human papillomavirus testing in the screening and management of cervical cancer precursors. Zhongguo Yi Xue Ke Xue Yuan Xue Bao [Internet]. 2007 Oct [cited 2018 Sep 14]; 29(5):691-6. PMID: 18051730. Disponible en: http://www.actacams.com/article/2007/1000-503X/1000-503X-29-5-691.pdf
Saslow D, Solomon D, Lawson H, Killackey M, Kulasingam S, Cain J, Garcia F, Moriarty A, A Waxman, Wilbur D, Wentzensen N, Downs L, Spitzer M, Moscicki A, Franco E, Stoler M, Schiffman M, Castle P, Myers E. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin [Internet]. 2012 Apr [cited 2018 Sep 14]; 137(4):516-42. DOI: https://doi.org/10.3322/caac.21139. Available from: https://onlinelibrary.wiley.com/doi/full/10.3322/caac.21139
Jeronimo J, Castle P, Temin S, Denny L, Gupta V, Kim J, Luciani S, Murokora D, Ngoma T, Qiao Y, Quinn M, Sankaranarayanan R, Sasieni P, Schmeler K, Shastri S. Secondary Prevention of Cervical Cancer Resource Stratified Guideline. J Glob Oncol [Internet]. 2016 Oct [cited 2018 Sep 14]; 635-657. DOI: 10.1200/JGO.2016.006577. Available from: https://ascopubs.org/doi/full/10.1200/JGO.2016.006577
Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin [Internet]. 2011 Feb [cited 2018 Sep 14]; 61(2):69-90. DOI: https://doi.org/10.3322/caac.20107. Available from: https://onlinelibrary.wiley.com/doi/full/10.3322/caac.20107
Sankaranarayanan R, Esmy P, Rajkumar R, Muwonge R, Swaminathan R, Shanthakumari S, Fayette J, Cherian J. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. The Lancet [Internet]. 2007 Aug 4 [cited 2018 Sep 14]; 370(9585):398-406. DOI: https://doi.org/10.1016/S0140-6736(07)61195-7. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(07)61195-7/fulltext
Shastri S, Mittra I, Mishra G, Gupta S, Dikshit R, Singh S, Badwe R. Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. J Natl Cancer Inst [Internet]. 2014 Mar [cited 2018 Sep 14]; 106(3). DOI: 10.1093/jnci/dju009. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24563518
International Federation of Gynecology & Obstetrics (FIGO). Guía global para la prevención y control del cáncer cervicouterino. Biblioteca virtual [Internet]. 2009 Oct [citado 2018 Sep 16]. Disponible en: http://whqlibdoc.who.int/publications/2007/9789243547008_spa.pdf
Pathak N, Dodds J, Zamora J, Khan K. Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis. BMJ Clinical Research [Internet]. 2014 Sep 16 [cited 2018 Sep 16]; 349:g5264. DOI: 10.1136/bmj.g5264. Available from: https://www.researchgate.net/publication/265792193_Accuracy_of_urinary_human_papillomavirus_testing_for_presence_of_cervical_HPV_Systematic_review_and_meta-analysis
Quaas J, Reich O, Küppers V. Explanation and Use of the Rio 2011 Colposcopy Nomenclature of the IFCPC (International Federation for Cervical Pathology and Colposcopy). Geburtshilfe Frauenheilkd [Internet]. 2014 Dec [cited 2018 Sep 16]; 74(12):1090-1092. DOI: 10.1055/s-0034-1383216. Available from: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0034-1383216
Calderón D, Cepeda F. Correlación colposcopía y estudio HP de cono LEEP. Rev. Ecuatoriana de Ginecología y Obstetricia 2009; XVI. (3). ISSN: 1390-5511.
McCredie M, Sharples K, Paul C, Baranyai J, Medley G, Jones R, Skegg D. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol [Internet]. 2008 May [cited 2018 Sep 16]; 9(5):425-34. DOI: 10.1016/S1470-2045(08)70103-7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/18407790
Yost N, Santoso J, McIntire D, Iliya F. Postpartum regression rates of antepartum cervical intraepithelial neoplasia II and III lesions. Obstet Gynecol [Internet]. 1999 Mar [cited 2018 Sep 17]; 93(3):359-62. Available from: https://www.ncbi.nlm.nih.gov/pubmed/10074979
McAllum B, Sykes P, Sadler L, Macnab H, Simcock B, Mekhail A. Is the treatment of CIN 2 always necessary in women under 25 years old?. Am J Obstet Gynecol [Internet]. 2011 Nov [cited 2018 Sep 17]; 205(5): 478-87. DOI: 10.1016/j.ajog.2011.06.069. Available from: https://www.ajog.org/article/S0002-9378(11)00814-3/abstract
American Society for Colposcopy and Cervical Pathology. 2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors. Journal of Lower Genital Tract Disease [Internet]. 2013 [cited 2018 Oct 3]; Volume 17, Number 5, 2013, S1-S27. Available from: https://www.asccp.org/.../asccp-updated-guidelines-3-21-13-pdf
Yan-Ming J, Chang-Xiang C, Li L. Meta-anallysis of cold knife conization versus loop electrosurgical excision procedure for cervical intraepithelial neoplasia. Onco Targets and Theraspy [Internet]. 2016 Jun [cited 2018 Oct 3]; 9: 3907–3915. DOI: 10.2147/OTT.S108832. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934869/
Calderón D, Moreno F, Calderón G. Ventajas del uso de policresuleno en mujeres sometidas a conización LEEP por lesión intraepitelial de alto grado en la unidad de colposcopía del servicio de Ginecología del Hospital Carlos Andrade Marín enero 2011 – diciembre 2012. CAMbios [Internet]. 2014 Dic [citado 2019 Nov 12]; XXII (22): 53-60. Disponible en: https://hcam.iess.gob.ec/wp-content/uploads/revista-cambios/REVISTA%2022%20imprenta.pdf
Manchanda R, Baldwin P, Crawford R, Vowler S, Moseley R, Latimer J, Welton K, Shafi M. Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50 years. BJOG [Internet]. 2008 Sep [cited 2019 Nov 12]; 115(10):1238-42. DOI: 10.1111/j.1471-0528.2008.01853.x. Available from: https://www.ncbi.nlm.nih.gov/pubmed/18715408
Russomano F, Reis A, Camargo M, Grinsztejn B, Tristão M. Recurrence of cervical intraepithelial neoplasia grades 2 or 3 in HIV-infected women treated by large loop excision of the transformation zone (LLETZ). Sao Paulo Med J [Internet]. 2008 Jan 2 [cited 2019 Nov 12]; 126(1):17-22. PMID: 18425282. Available from: https://www.ncbi.nlm.nih.gov/pubmed/18425282
Lima M, Tafuri A, Araújo A, de Miranda Lima L, Melo V. Cervical intraepithelial neoplasia recurrence after conization in HIV-positive and HIV-negative women. Int J Gynaecol Obstet [Internet]. 2009 Feb [cited 2019 Nov 12]; 104(2):100-4. DOI: 10.1016/j.ijgo.2008.10.009. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19062013
Tebeu P, Major A, Mhawech P, Rapiti E. The recurrence of cervical intraepithelial neoplasia in HIV-positive women: a review of the literature. Int J STD AIDS [Internet]. 2006 Aug [cited 2019 Nov 12]; 17(8):507-11. DOI: 10.1258/09564620677814570. Available from: https://www.ncbi.nlm.nih.gov/pubmed/16925893
Ebisch R, Rovers M, Bosgraaf R, van der Pluijm-Schouten H, Melchers W, van den Akker P, Massuger L, Bekkers R. Evidence supporting see-and-treat management of cervical intraepithelial neoplasia: a systematic review and meta-analysis. BJOG [Internet]. 2016 Jan [cited 2019 Nov 12]; 123(1):59-66. DOI: 10.1111/1471-0528.13530. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26177672
Los autores que publiquen en esta revista aceptan las siguientes condiciones:
1. Los autores conservan los derechos de autor y ceden a la REVISTA MÉDICA - CIENTÍFICA CAMbios HCAM el derecho de la primera publicación, con el trabajo registrado con la licencia de atribución de Creative Commons, que permite a terceros utilizar lo publicado siempre que mencionen la autoría del trabajo y a la primera publicación en esta revista.
2. Los autores pueden realizar otros acuerdos contractuales independientes y adicionales para la distribución no exclusiva de la versión del artículo publicado en esta revista (p. ej., incluirlo en un repositorio institucional o publicarlo en un libro) siempre que indiquen claramente que el trabajo se publicó por primera vez en la REVISTA MÉDICA-CIENTÍFICA CAMbios HECAM.
1.jpg)